Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Netflix
NFLX
|
+$1.23B |
| 2 |
CVS Health
CVS
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$723M |
| 4 |
Amazon
AMZN
|
+$682M |
| 5 |
Strategy Inc Common Stock Class A
MSTR
|
+$633M |
Top Sells
| 1 |
Corpay
CPAY
|
+$1.08B |
| 2 |
Booking.com
BKNG
|
+$827M |
| 3 |
ConocoPhillips
COP
|
+$544M |
| 4 |
Truist Financial
TFC
|
+$489M |
| 5 |
Merck
MRK
|
+$455M |
Sector Composition
| 1 | Technology | 22.2% |
| 2 | Communication Services | 15.23% |
| 3 | Financials | 14.97% |
| 4 | Healthcare | 13.69% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
UFP Industries
UFPI
$5.82B
| $22.4M | 0.01% |
301,905
+198,561
| +192% | +$14.8M |
|
|
DNMR
402
DELISTED
Danimer Scientific, Inc.
DNMR
| $22.3M | 0.01% |
22,243
-42
| -0.2% | -$42.1K |
|
403
Insulet
PODD
$24B
| $21.4M | ﹤0.01% |
77,900
| – | – |
|
404
Sandstorm Gold
SAND
$3.56B
| $20.8M | ﹤0.01% |
2,639,868
+1,278,568
| +94% | +$10.1M |
|
|
CLLS
405
Cellectis
CLLS
$300M
| $20.7M | ﹤0.01% |
1,339,336
| – | – |
|
|
EAR
406
DELISTED
Eargo, Inc. Common Stock
EAR
| $20.7M | ﹤0.01% |
25,896
+10,313
| +66% | +$8.23M |
|
407
Xenon Pharmaceuticals
XENE
$2.78B
| $19.7M | ﹤0.01% |
1,055,726
| – | – |
|
408
GoodRx Holdings
GDRX
$1.42B
| $19.4M | ﹤0.01% |
539,771
-23,465
| -4% | -$845K |
|
409
Monster Beverage
MNST
$62.8B
| $18.3M | ﹤0.01% |
400,848
+530
| +0.1% | +$24.2K |
|
410
Seer Inc
SEER
$115M
| $17.9M | ﹤0.01% |
544,694
-71,857
| -12% | -$2.36M |
|
411
Schrodinger
SDGR
$1.36B
| $17.5M | ﹤0.01% |
232,084
| – | – |
|
412
Hamilton Lane
HLNE
$6.43B
| $17.2M | ﹤0.01% |
+188,760
| New | +$17.2M |
|
413
Coca-Cola
KO
$285B
| $15.8M | ﹤0.01% |
291,465
-713
| -0.2% | -$38.6K |
|
414
Aveanna Healthcare
AVAH
$1.75B
| $15.4M | ﹤0.01% |
+1,246,000
| New | +$15.4M |
|
415
Fair Isaac
FICO
$37.3B
| $14.6M | ﹤0.01% |
29,100
| – | – |
|
|
GRCL
416
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $14.6M | ﹤0.01% |
1,122,533
| – | – |
|
|
KRON
417
DELISTED
Kronos Bio
KRON
| $14.4M | ﹤0.01% |
600,000
| – | – |
|
418
MarketAxess Holdings
MKTX
$6.79B
| $13.5M | ﹤0.01% |
29,200
| – | – |
|
419
iShares MSCI EAFE ETF
EFA
$67.5B
| $13.1M | ﹤0.01% |
164,954
-110,862
| -40% | -$8.81M |
|
|
ADAG
420
Adagene
ADAG
$99.4M
| $12.5M | ﹤0.01% |
923,269
| – | – |
|
|
NCNA
421
NuCana
NCNA
$8.59M
| $12.2M | ﹤0.01% |
883
| – | – |
|
422
Frontier Communications
FYBR
$9.37B
| $11.6M | ﹤0.01% |
+439,057
| New | +$11.6M |
|
|
AYX
423
DELISTED
Alteryx, Inc.
AYX
| $11.4M | ﹤0.01% |
133,000
| – | – |
|
424
iShares Core S&P 500 ETF
IVV
$679B
| $11.1M | ﹤0.01% |
25,890
+2,814
| +12% | +$1.21M |
|
425
Berkshire Hathaway Class A
BRK.A
$1.06T
| $10.9M | ﹤0.01% |
26
-18
| -41% | -$7.54M |
|